KR100720905B1 - 음이온성 또는 양이온성 덴드리머의 항균성 또는 구충성조성물 - Google Patents

음이온성 또는 양이온성 덴드리머의 항균성 또는 구충성조성물 Download PDF

Info

Publication number
KR100720905B1
KR100720905B1 KR1020017003211A KR20017003211A KR100720905B1 KR 100720905 B1 KR100720905 B1 KR 100720905B1 KR 1020017003211 A KR1020017003211 A KR 1020017003211A KR 20017003211 A KR20017003211 A KR 20017003211A KR 100720905 B1 KR100720905 B1 KR 100720905B1
Authority
KR
South Korea
Prior art keywords
dendrimers
dendrimer
iii
acid
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020017003211A
Other languages
English (en)
Korean (ko)
Other versions
KR20010075066A (ko
Inventor
매튜스배리로스
홀랜조오지
Original Assignee
스타파마 피티와이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스타파마 피티와이 리미티드 filed Critical 스타파마 피티와이 리미티드
Publication of KR20010075066A publication Critical patent/KR20010075066A/ko
Application granted granted Critical
Publication of KR100720905B1 publication Critical patent/KR100720905B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04Amoebicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/16Dendrimers and dendritic polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020017003211A 1998-09-14 1999-09-13 음이온성 또는 양이온성 덴드리머의 항균성 또는 구충성조성물 Expired - Lifetime KR100720905B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP5842A AUPP584298A0 (en) 1998-09-14 1998-09-14 Antimicrobial and antiparasitic agents
AUPP5842 1998-09-14

Publications (2)

Publication Number Publication Date
KR20010075066A KR20010075066A (ko) 2001-08-09
KR100720905B1 true KR100720905B1 (ko) 2007-05-25

Family

ID=3810064

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017003211A Expired - Lifetime KR100720905B1 (ko) 1998-09-14 1999-09-13 음이온성 또는 양이온성 덴드리머의 항균성 또는 구충성조성물

Country Status (12)

Country Link
US (1) US6464971B1 (https=)
EP (1) EP1113806B1 (https=)
JP (1) JP4979848B2 (https=)
KR (1) KR100720905B1 (https=)
CN (2) CN101352451A (https=)
AT (1) ATE372123T1 (https=)
AU (1) AUPP584298A0 (https=)
BR (1) BR9913712A (https=)
CA (1) CA2343113C (https=)
DE (1) DE69937059T2 (https=)
NZ (1) NZ510289A (https=)
WO (1) WO2000015240A1 (https=)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572459B2 (en) * 1998-09-14 2009-08-11 Starpharma Pty Ltd. Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
KR100413532B1 (ko) * 2001-02-14 2003-12-31 학교법인 포항공과대학교 폴리아민이 말단에 치환된 덴드리머 및 그 제조방법
AUPR412901A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agents for the prevention and treatment of sexually transmitted disease s - II
AUPR412801A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
WO2003049772A2 (en) * 2001-12-11 2003-06-19 The Board Of Trustees Of The Leland Stanford Junior University Guanidinium transport reagents and conjugates
AU2003256038A1 (en) * 2002-08-30 2004-03-19 Ramot At Tel Aviv University Ltd. Self-immolative dendrimers releasing many active moieties upon a single activating event
US20040234496A1 (en) * 2003-02-06 2004-11-25 Stockel Richard F. Biocidal compositions
US7074459B2 (en) * 2003-05-23 2006-07-11 Stockel Richard F Method for preserving wood
FR2862650B1 (fr) * 2003-11-24 2007-04-20 Rhodia Cons Spec Ltd Nouveaux dendrimeres a terminaisons monophosphoniques, leur procede de preparation et leur utilisation
FR2862651B1 (fr) * 2003-11-24 2006-03-31 Rhodia Cons Spec Ltd Nouveaux dendrimeres a terminaisons bisphosphoniques et derives, leur procede de preparation et leur utilisation
CN1296711C (zh) * 2004-05-14 2007-01-24 沈阳迈迪生物医学技术有限公司 乳腺癌的Her-2免疫组织化学诊断试剂盒
JP4553354B2 (ja) 2004-10-04 2010-09-29 正隆 井原 抗トリパノソーマ剤
US8790672B2 (en) * 2005-02-22 2014-07-29 Nina M. Lamba-Kohli Generation of antimicrobial surfaces using dendrimer biocides
US20060269480A1 (en) * 2005-05-31 2006-11-30 Ramot At Tel Aviv University Ltd. Multi-triggered self-immolative dendritic compounds
WO2007006700A1 (en) * 2005-07-08 2007-01-18 Janssen Pharmaceutica N.V. Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors
PL1937284T3 (pl) * 2005-10-18 2016-05-31 Starpharma Pty Ltd System podawania kompozycji bakteriobójczego dendymeru
WO2007045010A1 (en) * 2005-10-21 2007-04-26 Starpharma Pty Limited Inhibitory compounds
US8067402B2 (en) * 2005-12-12 2011-11-29 Allaccem, Inc. Methods and systems for coating an oral surface
JP5989294B2 (ja) 2006-01-20 2016-09-07 スターファーマ・プロプライエタリー・リミテッドStarpharma Pty Ltd 修飾高分子
EP1996209B1 (en) * 2006-03-22 2015-11-04 Starpharma Pty Limited Contraceptive composition
CA2683383C (en) 2007-02-21 2016-01-05 Allaccem, Incorporated Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
US20080282480A1 (en) * 2007-05-15 2008-11-20 The Hong Kong Polytechnic University Multifunction Finishing Liquids Containing Dendrimers and the Application of the Liquids in Textile Finishing
WO2009045237A1 (en) * 2007-05-21 2009-04-09 California Institute Of Technology Extraction of actinides from mixtures and ores using dendritic macromolecules
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20100008864A1 (en) * 2008-07-10 2010-01-14 Andreas Meijer Aromatic multimers
US9815712B2 (en) 2008-10-03 2017-11-14 California Institute Of Technology High capacity perchlorate-selective resins from hyperbranched macromolecules
WO2010040117A2 (en) * 2008-10-03 2010-04-08 California Institute Of Technology Extraction of anions from solutions and mixtures using hyperbranched macromolecules
US20120101041A1 (en) 2009-07-01 2012-04-26 Japan Science And Technology Agency Polyionic dendrimer and hydrogel comprising same
JP5212656B2 (ja) * 2009-09-02 2013-06-19 日産化学工業株式会社 イソチオシアナト化合物の製造方法
US8658702B2 (en) 2009-12-17 2014-02-25 Mamadou Diallo Soluble anion exchangers from hyperbranched macromolecules
CN103179855B (zh) * 2010-06-30 2015-07-08 刘慧文 抗菌化合物
RU2478106C2 (ru) * 2010-11-25 2013-03-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) СОЕДИНЕНИЯ НА ОСНОВЕ КОМПЛЕКСОВ ГИПЕРРАЗВЕТВЛЕННЫХ ПОЛИМЕРОВ Boltorn H, ОБЛАДАЮЩИЕ АНТИКАНДИДОЗНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
US9102602B2 (en) 2010-11-29 2015-08-11 Nissan Chemical Industries, Ltd. Method for producing isothiocyanate compound
KR20180126621A (ko) * 2011-05-16 2018-11-27 스타파마 피티와이 리미티드 세균성 질염의 치료 또는 예방 방법
WO2013074526A2 (en) 2011-11-15 2013-05-23 Byocoat Enterprises, Inc. Antimicrobial compositions and methods of use thereof
JP6419701B2 (ja) * 2012-09-13 2018-11-07 スターファーマ・ピーティーワイ・リミテッド 眼の感染症の治療または予防方法
EP2958429A4 (en) * 2013-02-20 2016-10-05 Biolog Inc COMPOSITIONS AND METHODS FOR INACTIVATION AND / OR REDUCTION OF MICROBIAL TOXIN PRODUCTION
ES2835382T3 (es) * 2013-03-15 2021-06-22 Boehringer Ingelheim Animal Health Usa Inc Composiciones de poliamidas antimicrobianas y tratamiento de la mastitis
GB201405660D0 (en) * 2014-03-28 2014-05-14 Gama Healthcare Ltd A liquid disinfecting composition
CN103999853B (zh) * 2014-06-11 2015-07-22 中国农业大学 荧光树枝状纳米大分子在制备药物载体中的应用
US9854806B2 (en) 2015-05-19 2018-01-02 International Business Machines Corporation Antimicrobial guanidinium and thiouronium functionalized polymers
MX379091B (es) * 2016-04-14 2025-03-10 Boehringer Ingelheim Animal Health Usa Inc Composiciones de múltiples dosis que contienen un conservador de poliamida antimicrobiana u octenidina.
WO2018081861A1 (en) * 2016-11-02 2018-05-11 The University Of Melbourne Antimicrobial composition combinations comprising star shaped peptide polymers
WO2018081845A1 (en) 2016-11-02 2018-05-11 The University Of Melbourne Antibacterial compositions and methods
US10953039B2 (en) 2018-09-27 2021-03-23 International Business Machines Corporation Utilizing polymers and antibiotics to enhance antimicrobial activity and inhibit antibiotic resistance
CN110041523B (zh) * 2019-04-15 2021-04-30 同济大学 低代树枝状聚赖氨酸类抗菌肽及其制备方法
CN114053392B (zh) * 2020-07-30 2024-06-21 广州朗圣药业有限公司 新型化合物在制备预防和/或治疗hpv感染的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
US5658574A (en) 1995-10-13 1997-08-19 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cleansing compositions with dendrimers as mildness agents
DE19624705A1 (de) * 1996-06-20 1998-01-08 Deutsches Krebsforsch Dendrimere auf Saccharid-Basis
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
WO1998026662A1 (en) 1996-12-19 1998-06-25 The Penn State Research Foundation Compounds and methods for treating and preventing bacterial and viral disease
AUPP584398A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Inhibition of toxic materials or substances

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
국제공개특허 제95/34595호
국제공개특허 제98/26662호

Also Published As

Publication number Publication date
WO2000015240A1 (en) 2000-03-23
DE69937059D1 (de) 2007-10-18
CA2343113A1 (en) 2000-03-23
AUPP584298A0 (en) 1998-10-08
JP2002524524A (ja) 2002-08-06
JP4979848B2 (ja) 2012-07-18
BR9913712A (pt) 2001-05-29
NZ510289A (en) 2002-10-25
KR20010075066A (ko) 2001-08-09
EP1113806B1 (en) 2007-09-05
EP1113806A1 (en) 2001-07-11
DE69937059T2 (de) 2008-05-29
EP1113806A4 (en) 2003-06-25
ATE372123T1 (de) 2007-09-15
CN101352451A (zh) 2009-01-28
US6464971B1 (en) 2002-10-15
CN1323214A (zh) 2001-11-21
CA2343113C (en) 2009-11-24

Similar Documents

Publication Publication Date Title
KR100720905B1 (ko) 음이온성 또는 양이온성 덴드리머의 항균성 또는 구충성조성물
US6426067B1 (en) Angiogenic inhibitory compounds
CN108472358B (zh) 具有免疫赋活活性的核酸衍生物
CZ194693A3 (en) Copolymers polyoxypropylene/polyoxyethylene with enhanced biological activity
KR20010075089A (ko) 덴드리머를 사용한 유독 물질의 억제 방법
JPH10502925A (ja) ラムノリピド類の免疫活性
BG63048B1 (bg) Цитостатици, модифицирани с въглехидрати
US20030129158A1 (en) Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
TW201615694A (zh) 主鏈型聚胺類
KR100884848B1 (ko) 세균감염을 치료 또는 예방하기 위한 방법 및 조성물
CN117285707A (zh) 低毒性、高抗菌活性的β-多肽聚合物的制备方法及应用
CN115838409A (zh) 一种pH响应性Cecropin B抗菌多肽的制备方法与应用
AU767970B2 (en) Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
AU767971B2 (en) Inhibition of toxic materials or substances using dendrimers
FI81807C (fi) Foerfarande foer framstaellning av 2,3-diamino-2,3-didesoxyhexosderivativer.
MXPA01002667A (en) Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
AU715761C (en) Angiogenic inhibitory compounds
MXPA01002665A (en) Inhibition of toxic materials or substances using dendrimers
MXPA99000655A (es) Compuestos inhibidores angiogenicos
EP0777644A1 (en) D-b-lysylmethanediamine derivatives with bacteria, aids virus and tumor cell growth inhibiting activity and preparation thereof

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010313

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20040910

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060331

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20061124

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20060331

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20070227

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20061124

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20070409

Appeal identifier: 2007101002241

Request date: 20070227

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20070227

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20070227

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20060929

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20040910

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20070409

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20070402

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20070516

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20070517

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
G170 Re-publication after modification of scope of protection [patent]
PG1701 Publication of correction

Publication date: 20080424

FPAY Annual fee payment

Payment date: 20100512

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20100512

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20110422

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20110422

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20120503

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20120503

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20130502

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20130502

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20140512

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20140512

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20150430

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20150430

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20160427

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20160427

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20170515

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20170515

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20180504

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20180504

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20190508

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20190508

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term